Publikationsverzeichnis (Justine Rochon) Ludt, S., Wensing, M., Campbell, S.M., Ose, D., van Lieshout, J., Rochon, J., Uhlmann, L., & Szecsenyi, J. (in press). The challenge of cardiovascular prevention in primary care: implications of a European observational study in 8928 patients at different risk levels. European Journal of Preventive Cardiology. Glockzin, G., Rochon, J., Arnold, D., Lang, S.A., Klebl, F., Zeman, F., Koller, M., Schlitt, H.J., & Piso, P. (2013). A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial. BMC Cancer, 13, 67. Ludt, S., Campbell, S.M., Petek, D., Rochon, J., Szecsenyi, J., van Lieshout, J., Wensing, M., & Ose, D. (2013). Which practice characteristics are associated with the quality of cardiovascular disease prevention in European primary care? Implementation Science, 8, 27. Spitalewsky, K., Rochon, J., Ganzinger, M., & Knaup, P. (2013). Potential and requirements of IT for ambient assisted living technologies: Results of a Delphi Study. Methods of Information in Medicine, 52, 231–238. Ose, D., Rochon, J., Campbell, S.M., Wensing, M., van Lieshout, J., Uhlmann, L., Freund, T., Szecsenyi, J. & Ludt, S. (2012). Secondary prevention in patients with coronary heart diseases: What factors are associated with health status in usual primary care? PLoS ONE, 7, e51726. Erler, A., Beyer, M., Petersen, J.J., Saal, K., Rath, T., Rochon, J., Haefeli, W.E., & Gerlach, F. (2012). How to improve drug dosing for patients with renal impairment in primary care – A cluster‐randomized controlled trial. BMC Family Practice, 13, 91. Haasenritter, J., Stanze, D., Widera, G., Wilimzig, C., Abu Hani, M., Sönnichsen, A., Bösner, S., Rochon, J., & Donner‐Banzhoff, N. (2012). Does the patient with chest pain have a coronary heart disease? Diagnostic value of single symptoms and signs – a meta‐
analysis. Croatian Medical Journal, 53, 432–441. Ludt, S., van Lieshout, J., Campbell, S.M., Rochon, J., Ose, D., Freund, T., Wensing, M., & Szecsenyi, J. (2012). Identifying factors associated with experiences of coronary heart disease patients receiving structured chronic care and counselling in European primary care. BMC Health Services Research, 12, 221. Rochon, J., Gondan, M., & Kieser, M. (2012). To test or not to test: Preliminary assessment of normality when comparing two independent samples. BMC Medical Research Methodology, 12, 81. Heitz, F., du Bois, A., Rochon, J., Scheil‐Bertram, S., Hils, R., Fisseler‐Eckhoff, A., Barinoff, J., Kaub, C., & Harter, P. (2012). Requirements to assess feasibility of phase 0 trials during major abdominal surgery: variability of PARP activity. Clinical Cancer Research, 18, 2632–2637. Keller, H., Krones, T., Becker, A., Hirsch, O., Sönnichsen, A.C., Popert, U., Kaufmann‐Kolle, P., Rochon, J., Wegscheider, K., Baum, E., & Donner‐Banzhoff, N. (2012). Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice. European Journal of Cardiovascular Prevention & Rehabilitation, 19, 322–329. Feigl, G.C., Schebesch K.M., Rochon, J., Warnat, J., Woertgen, C., Schmidt, S., Lange, M. Schlaier, J., & Brawanski, A.T. (2011). Analysis of risk factors influencing the development of severe dizziness in patients with vestibular schwannomas in the immediate postoperative phase. Clinical Neurology and Neurosurgery, 113, 52–56. 1 of 4
Freund, T., Peters‐Klimm, F., Rochon, J., Mahler, C., Gensichen, J., Erler, A., Beyer, M., Baldauf, A., Gerlach, F., & Szecsenyi, J. (2011). Primary care practice‐based care management for chronically ill patients (PraCMan): study protocol for a cluster randomized controlled trial [ISRCTN56104508]. Trials, 12, 163. Goetz, K., Campbell, S.M., Willms, S., Rochon, J., Klingenberg, A., & Szecsenyi, J. (2011). How do chronically ill patients evaluate their medical care? An observational study with 46919 patients in 676 primary care practices. International Journal of Person‐
Centered Medicine, 1, 338–346. Heitz, F., Rochon, J., Harter, P., Lueck, H.J., Fisseler‐Eckhoff, A., Barinoff, J., Traut, A., Lorenz‐
Salehi, F., & du Bois, A. (2011). Cerebral metastases in metastatic breast cancer: disease‐specific risk factors and survival. Annals of Oncology, 22, 1571–1581. Ludt, S., Wensing, M., Szecsenyi, J., van Lieshout, J., Rochon, J., Freund, T., Campbell, S.M., & Ose, D. (2011). Predictors of health‐related quality of life in patients at risk for cardiovascular disease in European primary care. PLoS ONE, 6, e29334. Oberacher‐Velten, I., Prasser, C., Rochon, J., Ittner, K.P., Helbig, H., & Lorenz, B. (2011). The effects of midazolam on intraocular pressure in children during examination under sedation. British Journal of Ophthalmology, 95, 1102–1105. Pater, J., Rochon, J., Parmar, M.K., & Selby, P. (2011). Future research and methodological approaches. Annals of Oncology, 22(Suppl. 7), vii57–vii61. Rochon, J., & du Bois, A. (2011). Clinical research in epithelial ovarian cancer and patients' outcome. Annals of Oncology, 22(Suppl. 7), vii16–vii19. Rochon, J., & Kieser, M. (2011). A closer look at the effect of preliminary goodness‐of‐fit testing for normality for the one‐sample t‐test. British Journal of Mathematical and Statistical Psychology, 64, 410–426. Hilpert, F., Harter, P., Pfisterer, J., Rochon, J., Friedemann, J., Lamparter, C., & du Bois, A. (2010). Eigenverantwortliche Qualitätssicherung zur Therapiequalität des Ovarialkarzinoms in Deutschland. Gynäkologe, 43, 1022–1027. Kommoss, S., Rochon, J., Harter, P., Heitz, F., Grabowski, J.P., Ewald‐Riegler, N., Haberstroh, M., Neunhoeffer, T., Barinoff, J., Gomez, R., Traut, A., & du Bois, A. (2010). Prognostic impact of extended surgical procedures in advanced‐stage primary ovarian cancer. Annals of Surgical Oncology, 17, 279–286. Moritz, S., Rochon, J., Völkel, S., Hilker, M., Hobbhahn, J., & Arlt, M. (2010). Determinants of cerebral oximetry in patients undergoing off‐pump coronary artery bypass grafting: An observational study. European Journal of Anaesthesiology, 27, 542–549. Schnitzbauer, A.A., Scherer, M.N., Rochon, J., Sothmann, J., Farkas, S.A., Loss, M., Geissler, E.K., Obed, A., & Schlitt, H.J. (2010). Study protocol: a pilot study to determine the safety and efficacy of induction‐therapy, de novo MPA and delayed mTOR‐inhibition in liver transplant recipients with impaired renal function. PATRON‐study. BMC Nephrology, 11, 24. Schnitzbauer, A.A., Zuelke, C., Graeb, C., Rochon, J., Bilbao, I., Burra, P., de Jong, K.P., Duvoux, C., Kneteman, N.M., Adam, R., Bechstein, W.O., Becker, T., Beckebaum, S., Chazouillières, O., Cillo, U., Colledan, M., Fändrich, F., Gugenheim, J., Hauss, J.P., Heise, M., Hidalgo, E., Jamsieson, N., Königsrainer, A., Lamby, P., Lerut, J.P., Mäkisalo, H., Margreiter, R., Mazzaferro, V., Mutzbauer, I., Otto, G., Pageuax, G.P., Pinna, A., Pirenne, J., Rizell, M., Rossi, G., Rostaing, L., Roy, A., Turrion, V.S., Schmidt, J., Troisi, R.I., van Hoek, B., Valente, U., Wolf, P., Wolters, H., Mirza, D.F., Scholz, T., Steininger, R., Soderdahl, G., Strasser, S.I., Jauch, K.W., Neuhaus, P., Schlitt, H.J., & Geissler, E.K. (2010). A prospective randomised, open‐labeled, trial comparing sirolimus‐containing 2 of 4
versus mTOR‐inhibitor‐free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer, 10, 190. du Bois, A., Rochon, J., Pfisterer, J., & Hoskins, W.J. (2009). Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: A systematic review. Gynecologic Oncology, 112, 422–436. du Bois, A., Rochon, J., Lamparter, C., & Pfisterer, J. (2009). Die Qualität der Rezidivtherapie beim Ovarialkarzinom in Deutschland ‐ Qualitätssicherungserhebung im Rahmen des Aktionsprogramms der AGO Kommission OVAR (QS‐OVAR). Frauenarzt, 50, 952–959. du Bois, A., Rochon, J., Lamparter, C., & Pfisterer, J. (2009). Die Qualität der Therapie des Ovarialkarzinoms in Deutschland. Frauenarzt, 50, 742–751. du Bois, A., Rochon, J., Lamparter, C., Elser, G., & Pfisterer, J. (2009). Versorgungsstruktur, Qualitätssicherung und klinische Studien beim invasiven Ovarialkarzinom in Deutschland – Aktionsprogramm QS‐OVAR der AGO und Aktivitäten der AGO Studiengruppe. In: R. Kreienberg, A. du Bois, J. Pfisterer, S. Schindelmann, B. Schmalfeldt (Hrsg.) Management des Ovarialkarzinoms. Heidelberg: Springer Medizin Verlag. Schade‐Brittinger, C., Reuß, A., & Rochon, J. (2009). Studiendesign. In: R. Kreienberg, A. du Bois, J. Pfisterer, S. Schindelmann, B. Schmalfeldt (Hrsg.) Management des Ovarialkarzinoms. Heidelberg: Springer Medizin Verlag. Krones, T., Keller, H., Sönnichsen, A., Sadowski, E., Baum, E., Wegscheider, K., Rochon, J., & Donner‐Banzhoff, N. (2008). Absolute cardiovascular risk and shared decision‐making in primary care: A single‐blind cluster randomized controlled trial. Annals of Family Medicine, 6, 218–227. Sassen, A., Rochon, J., Wild, P., Hartmann, A., Hofstädter, F., Schwarz, S., & Brockhoff, G. (2008). Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients. Breast Cancer Research, 10, R2. Hattemer, K., Knake, S., Reis, J., Rochon, J., Oertel, W., Rosenow, F., & Hamer, H. (2007). Excitability of the motor cortex during ovulatory and anovulatory cycles: a transcranial magnetic stimulation study. Clinical Endocrinology, 66, 387–393. Keller, H., Krones, T., Sönnichsen, A., Sadowski, E., Popert, U., Rochon, J., Kaufmann‐Kolle, P., Szecsenyi, J., Baum, E., & Donner‐Banzhoff, N. (2007). Medikamentöse Prävention von kardiovaskulären Erkrankungen: Verschreiben Hausärzte risikoangemessen? Zeitschrift für Allgemeinmedizin, 83, 359–364. du Bois, A., Weber, B., Rochon, J., Meier, W., Gaupil, A., Olbricht, S., Berats, J.C., Kuhn, W., Orfeuvre, H., Wagner, U., Richter, B., Lueck, H.J., Pfisterer, J., Costa, S., Schroeder, W., Kimmig, R., & Pujade‐Lauraine, E. for AGO‐OVAR and GINECO (2006). Addition of epirubicin as a third drug to carboplatin‐paclitaxel in first‐line treatment of advanced ovarian cancer: A prospectively randomized Gynecologic Cancer Intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens. Journal of Clinical Oncology, 24, 1127–1135. Knake, S., Rochon, J., Fleischer, S., Katsarou, N., Back, T., Vescovi, M., Oertel, W., Reis, J., Hamer, H., & Rosenow, F. (2006). Status epilepticus after stroke is associated with increased long‐term case fatality. Epilepsia, 47, 2020–2026. Pfisterer, J., Plante, M., Vergote, I., du Bois, A., Hirte, H., Lacave, A.J., Wagner, U., Stahle, A., Stuart, G., Kimmig, R., Olbricht, S., Le, T., Emerich, J., Kuhn, W., Bentley, J., Jackisch, C., Lueck, H.J., Rochon, J., Zimmermann, A.H., & Eisenhauer, E. (2006). Gemcitabine plus carboplatin compared with carboplatin in patients with platinum‐sensitive 3 of 4
recurrent ovarian cancer: an intergroup trial of the AGO‐OVAR, the NCIC CTG, and the EORTC GCG. Journal of Clinical Oncology, 24, 4699–4707. du Bois, A., Rochon, J., Lamparter, C., & Pfisterer, J. (2005). Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer. International Journal of Gynecological Cancer, 15, 183–191. du Bois, A., Rochon, J., Lamparter, C., & Pfisterer, J. (2005). Welchen Einfluss haben Klinikmerkmale auf die Prognose beim Ovarialkarzinom in Deutschland? Zentralblatt für Gynäkologie, 127, 18–30. du Bois, A., Rochon, J., Lamparter, C., & Pfisterer, J. (2005). Das Qualitätssicherungs‐
programm der AGO Organkommission OVAR (QS‐OVAR): Versorgungsstruktur und Realität in Deutschland 2001. Zentralblatt für Gynäkologie, 127, 9–17. du Bois, A., Quinn, M., Thigpen, T., Vermorken, J.B., Avall‐Lundqvist, E., Bookman, M., Bowtell, D., Brady, M., Casado, A., Cervantes, A., Eisenhauer, E., Friedlaender, M., Fujiwara, K., Grenman, S., Guastalla, J.P., Harper, P., Hogberg, T., Kaye, S., Kitchener, H., Kristensen, G., Mannel, R., Meier, W., Miller, B., Neijt, J.P., Oza, A., Ozols, R., Parmar, M.K., Pecorelli, S., Pfisterer, J., Poveda, A., Provencher, D., Pujade‐Lauraine, E., Randall, M., Rochon, J., Rustin, G., Sagae, S., Stehman, F., Stuart, G., Trimble, E., Vasey, P., Vergote, I., Verheijen, R., & Wagner, U. (2005). 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Annals of Oncology, 16(Suppl. 8), viii7–viii12. Nonnenmacher, C., Dalpke, A., Rochon, J., Flores‐de‐Jacoby, L., Mutters, R., & Heeg, K. (2005). Real‐time polymerase chain reaction for detection and quantification of bacteria in periodontal patients. Journal of Periodontology, 76, 1542–1549. Stuart, G., Avall‐Lundqvist, E., du Bois, A., Bookman, M., Bowtell, D., Brady, M., Casado, A., Cervantes, A., Eisenhauer, E., Friedlaender, M., Fujiwara, K., Grenman, S., Guastalla, J.P., Harper, P., Hogberg, T., Kaye, S., Kitchener, H., Kristensen, G., Mannel, R., Meier, W., Miller, B., Oza, A., Ozols, R., Parmar, M.K., Pfisterer, J., Poveda, A., Provencher, D., Pujade‐Lauraine, E., Quinn, M., Randall, M., Rochon, J., Rustin, G., Sagae, S., Stehman, F., Trimble, E., Thigpen, T., Vasey, P., Vergote, I., Verheijen, R., Vermorken, J.B., & Wagner, U. (2005). 3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration. Annals of Oncology, 16(Suppl. 8), viii36–viii38. Vermorken, J.B., Parmar, M.K., Brady, M.F., Eisenhauer, E.A., Hogberg, T., Ozols, R.F., Rochon, J., Rustin, G.J., Sagae, S., & Verheijen, R.H. (2005). Clinical trials in ovarian carcinoma: study methodology. Annals of Oncology, 16(Suppl. 8), viii20–viii29. 4 of 4